Characterization of human papillomavirus in airway papillomas by histologic and biochemical analysis

Annals of Otology, Rhinology and Laryngology

Volumn 108, Issue 11 I, 1999, Pages 1073-1077

  Glynn, Matthew ^a   Sanford, Thomas ^a,b   Hoover, Larry ^a   Kinsey, William ^a   Dobbs, Larry ^a   Bruegger, Daniel ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Human papillomavirus; Recurrent respiratory papillomatosis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; HUMAN; LARYNX DISORDER; LARYNX PAPILLOMATOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0032710103     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949910801109     Document Type: Article

References (17)

1. Kashima HK. Recurrent respiratory papillomatosis. In: Gates GA, ed. Current therapy in otolaryngology - head and neck surgery. 5th ed. St Louis, Mo: Mosby-Year Book, 1994:441-3.
2. Avidano MA, Singleton GT. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1995;112:197-202.
3. Kashima H, Mounts P, Leventhal B, Hruban RH. Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 1993;102:580-3.
4. Braun L, Kashima HK, Eggleston J, Shah K. Demonstration of papillomavirus antigen in paraffin sections of laryn-geal papillomas. Laryngoscope 1982;92:640-3.
5. Gissmann L, Diehl V, Schultz-Coulon H-J, Zur-Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 1982;44: 393-400.
6. Steinberg BM, Topp WC, Schneider PS, Abramson AL. Laryngeal papillomavirus infection during clinical remission. N Engl J Med 1983;308:1261-4.
7. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Cancer cells. Vol 7. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989:209-14.
8. Benjamin B, Parsons D. Recurrent respiratory papillomatosis: a 10 year study. J Laryngol Otol 1988;102:1022-8.
9. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope 1987;97:678-85.
10. Smith EM, Pignatari SS, Gray SD, et al. Human papillomavirus infection in papilloma and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993;119:554-7.
11. 2)-laser therapy cures macroscopic lesions, but viral genome is not eradicated in men with therapy-resistant HPV infection. Sex Transm Dis 1994;21:297-302.
12. 2 laser plume from recurrent respiratory papilloma. Otolaryngol Head Neck Surg 1991;104:191-5.
13. Abramson AL, DiLorenzo TP, Steinberg BM. Is papillomavirus detectable in the plume of laser-treated laryngeal papilloma? Arch Otolaryngol Head Neck Surg 1990;116:604-7.
14. Stern LS, Abramson AL, Grimes GW. Qualitative and morphometric evaluation of vocal cord lesions produced by the carbon dioxide laser. Laryngoscope 1980;90:792-808.
15. Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Amell CA, Rothstein HR. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg 1992;118:25-30.
16. Saleh EM. Complications of treatment of recurrent laryngeal papillomatosis with the carbon dioxide laser in children. J Laryngol Otol 1992; 106:715-8.
17. 2 laser ablation and cup forceps stripping. Otolaryngol Head Neck Surg 1986;95:273-7.